Solid State R&D & Pre-Formulation

Eurofins CDMO Alphora is a Canadian contract development and manufacturing organization (CDMO) with FDA- and Health Canada-inspected facilities, offering specialized expertise in Solid-State Research and Development (SSRD) and pre-formulation services for small molecule drug programs. Our integrated scientific approach helps sponsors establish a strong foundation for successful drug development by addressing critical physicochemical and biopharmaceutical considerations early in the development process.

At the discovery stage, our SSRD and pre-formulation services support candidate ranking and selection by generating key data to inform development decisions while accommodating limited material availability and accelerated timelines. Through comprehensive solid-state characterization, salt and polymorph screening, crystallization studies, particle engineering, and biopharmaceutical assessments, we help identify and mitigate potential development risks before they impact downstream activities.

Our SSRD capabilities can be delivered as standalone services or seamlessly integrated into API and drug product development programs. Guided by Quality by Design (QbD) principles, our experienced scientists develop tailored strategies that optimize product performance, manufacturability, stability, and regulatory readiness across all stages of pharmaceutical development—from candidate selection and IND-enabling studies through commercialization.